Firms
Theme

AX

Axos Financial, Inc. · NYSE

News

3 latest

Zacks Investment Research

Wall Street Analysts Predict a 30.99% Upside in Axos Financial (AX): Here's What You Should Know

Axos Financial (AX) has gained 0.8% over the past four weeks and closed at $89.86. Wall Street analysts have set a mean price target of $117.71, indicating a potential 31% upside.

Mentions AX

Zacks Investment Research

Rithm (RITM) Surpasses Q3 Earnings and Revenue Estimates

Rithm (RITM) reported Q3 2026 earnings of $0.55 per share, beating consensus estimates of $0.51, with revenues of $1.76 billion surpassing expectations by 17.71%. However, the stock received a Zacks Rank #4 (Sell) rating due to unfavorable estimate revision trends. The company has underperformed the S&P 500 by 20.4% year-to-date, and its industry ranks in the bottom 28% of Zacks industries.

GlobeNewswire Inc.

CodeWall Emerges from Stealth with $4M to Give Every Enterprise an Attacker of Its Own

CodeWall, a London-based enterprise security startup, has raised $4 million in pre-seed funding led by Osney Capital to develop autonomous attack agents that simulate external threats. The platform helps enterprises identify exploitable vulnerabilities by continuously testing defenses from an attacker's perspective without requiring credentials or inside access. The company is already working with financial institutions and has demonstrated its capabilities across major consulting firms.

Headlines link to the publisher. Not investment advice.

Analysts

All ›

Targets are shown as reported, adjusted only for stock splits, not as predictions. Not investment advice.

Community

7 days

No sentiment yet

Posts 24h
0
Replies 24h
0
Watchers
0

Board · $AX · 0 threads

Sign in to post on $AX

No threads yet

Community posts are member opinions. Desk posts are automated weekly counts. Not investment advice.

Cylvex is a financial simulation and community platform designed for educational and informational purposes only. Market data may be delayed. Nothing on this platform constitutes investment advice, financial advice, trading advice, or any other sort of advice. You should not treat any of the platform's content as such. Cylvex does not recommend that any financial instrument should be bought, sold, or held by you. Do conduct your own due diligence and consult your financial advisor before making any investment decisions. By using Cylvex, you acknowledge that you are using the platform at your own risk.

Terms · Privacy · Disclaimer · Methodology · Logos provided by Logo.dev